{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:34:24Z","timestamp":1789565664378,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.vaccine.2021.09.037","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T04:08:06Z","timestamp":1632715686000},"page":"A93-A104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"S1","title":["Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic"],"prefix":"10.1016","volume":"41","author":[{"given":"Natalia A","family":"Molodecky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana M","family":"Safdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal A","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdirahman","family":"Mahamud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda S","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshad","family":"Quddus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Zaffran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland W","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C","family":"Grassly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isobel M","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.09.037_b0005","unstructured":"GPEI. Call to action to support COVID-19 response. Polio Oversight Board Statement. Available at: http:\/\/polioeradication.org\/news-post\/call-to-action-to-support-covid-19-response\/."},{"key":"10.1016\/j.vaccine.2021.09.037_b0010","unstructured":"GPEI. Circulating vaccine-derived poliovirus. Available at: http:\/\/polioeradication.org\/polio-today\/polio-now\/this-week\/circulating-vaccine-derived-poliovirus\/."},{"issue":"6489","key":"10.1016\/j.vaccine.2021.09.037_b0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.aba1238","article-title":"Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine","volume":"368","author":"Macklin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2021.09.037_b0020","unstructured":"L. V. Cooper et al., Risk factors for spread of vaccine-derived type 2 polioviruses in Africa following global withdrawal of trivalent oral poliovirus vaccine and impact of outbreak response with monovalent vaccine: a retrospective analysis of surveillance data. Lancet Infectious Diseases (in press)."},{"key":"10.1016\/j.vaccine.2021.09.037_b0025","unstructured":"GPEI. SOPs Responding to a poliovirus event of outbreak. March 2020. Available at: https:\/\/polioeradication.org\/wp-content\/uploads\/2020\/04\/POL-SOP-V3.1-20200424.pdf."},{"key":"10.1016\/j.vaccine.2021.09.037_b0030","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.4269\/ajtmh.20-1010","article-title":"Polio in Afghanistan: The Current Situation amid COVID-19","volume":"103","author":"Ahmadi","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2021.09.037_b0035","doi-asserted-by":"crossref","unstructured":"S. Ahmad et al., Polio Amidst COVID-19 in Pakistan: What are the Efforts Being Made and Challenges at Hand? Am J Trop Med Hyg 104, 446-448 (2020).","DOI":"10.4269\/ajtmh.20-1438"},{"issue":"4","key":"10.1016\/j.vaccine.2021.09.037_b0040","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2190","article-title":"Impact of COVID-19 on polio vaccination in Pakistan: a concise overview","volume":"31","author":"Din","year":"2021","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2021.09.037_b0045","unstructured":"WHO. Essential polio vaccination campaigns resume after strict COVID-19 prevention measures. Available at: http:\/\/www.emro.who.int\/fr\/polio\/polio-news\/essential-polio-vaccination-campaigns-resume-under-strict-covid-19-prevention-measures.html."},{"key":"10.1016\/j.vaccine.2021.09.037_b0050","unstructured":"Afghanistan National Emergency Action Plan for Polio Eradication. 2021. Available at: https:\/\/polioeradication.org\/wp-content\/uploads\/2021\/05\/Afghanistan_NEAP_2021.pdf."},{"key":"10.1016\/j.vaccine.2021.09.037_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002323","article-title":"Risk factors and short-term projections for serotype-1 poliomyelitis incidence in Pakistan: A spatiotemporal analysis","volume":"14","author":"Molodecky","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.vaccine.2021.09.037_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002140","article-title":"Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data","volume":"13","author":"Pons-Salort","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.vaccine.2021.09.037_b0065","unstructured":"Laboratory surveillance for wild and vaccine-derived polioviruses--worldwide, January 2007-June 2008. MMWR. Morbidity and mortality weekly report 57, 967-970 (2008)."},{"issue":"12","key":"10.1016\/j.vaccine.2021.09.037_b0070","doi-asserted-by":"crossref","first-page":"e113538","DOI":"10.1371\/journal.pone.0113538","article-title":"Quantifying the impact of expanded age group campaigns for polio eradication","volume":"9","author":"Wagner","year":"2014","journal-title":"PLoS ONE"},{"issue":"5802","key":"10.1016\/j.vaccine.2021.09.037_b0075","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.1130388","article-title":"New strategies for the elimination of polio from India","volume":"314","author":"Grassly","year":"2006","journal-title":"Science"},{"issue":"29","key":"10.1016\/j.vaccine.2021.09.037_b0080","doi-asserted-by":"crossref","first-page":"10604","DOI":"10.1073\/pnas.1323688111","article-title":"The role of older children and adults in wild poliovirus transmission","volume":"111","author":"Blake","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7392","key":"10.1016\/j.vaccine.2021.09.037_b0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature10856","article-title":"A universal model for mobility and migration patterns","volume":"484","author":"Simini","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2021.09.037_b0095","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1016\/S2214-109X(17)30184-5","article-title":"Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial","volume":"5","author":"Habib","year":"2017","journal-title":"The Lancet. Global health"},{"key":"10.1016\/j.vaccine.2021.09.037_b0100","first-page":"207","article-title":"Development of neutralizing antibodies against the three types of poliomyelitis virus during an epidemic period; the ratio of inapparent infection to clinical poliomyelitis","volume":"58","author":"Melnick","year":"1953","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2021.09.037_b0105","first-page":"195","article-title":"The paralytic\/infected ratio in a susceptible population during a polio type I epidemic","volume":"39","author":"Penttinen","year":"1961","journal-title":"Ann Med Exp Biol Fenn"},{"issue":"11","key":"10.1016\/j.vaccine.2021.09.037_b0110","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/aje\/kwq320","article-title":"From emergence to eradication: the epidemiology of poliomyelitis deconstructed","volume":"172","author":"Nathanson","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2021.09.037_b0115","first-page":"367","article-title":"Studies on the development of natural immunity to poliomyelitis in Louisiana. II. Description and analysis of episodes of infection observed in study group households","volume":"65","author":"Gelfand","year":"1957","journal-title":"Am J Hyg"},{"issue":"7","key":"10.1016\/j.vaccine.2021.09.037_b0120","doi-asserted-by":"crossref","first-page":"e1005728","DOI":"10.1371\/journal.ppat.1005728","article-title":"Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame","volume":"12","author":"Pons-Salort","year":"2016","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.vaccine.2021.09.037_b0125","doi-asserted-by":"crossref","first-page":"e3433","DOI":"10.1371\/journal.pone.0003433","article-title":"Estimating the extent of vaccine-derived poliovirus infection","volume":"3","author":"Wringe","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.09.037_b0130","doi-asserted-by":"crossref","unstructured":"N. C. Grassly et al., Waning intestinal immunity after vaccination with oral poliovirus vaccines in India. The Journal of infectious diseases 205, 1554-1561 (2012).","DOI":"10.1093\/infdis\/jis241"},{"key":"10.1016\/j.vaccine.2021.09.037_b0135","doi-asserted-by":"crossref","first-page":"100059","DOI":"10.1016\/j.jvacx.2020.100059","article-title":"New analytic approaches for analyzing and presenting polio surveillance data to supplement standard performance indicators","volume":"4","author":"VanderEnde","year":"2020","journal-title":"Vaccine X"},{"key":"10.1016\/j.vaccine.2021.09.037_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v069.i12","article-title":"Statistical Inference for Partially Observed Markov Processes via the R Package pomp","volume":"69","author":"King","year":"2016","journal-title":"J Stat Softw"},{"key":"10.1016\/j.vaccine.2021.09.037_b0145","unstructured":"Google. COVID-19 Community Mobility Reports. Available at: https:\/\/www.google.com\/covid19\/mobility\/."},{"key":"10.1016\/j.vaccine.2021.09.037_b0150","doi-asserted-by":"crossref","unstructured":"S. Chandir, D. A. Siddiqi, H. Setayesh, A. J. Khan, Impact of COVID-19 lockdown on routine immunisation in Karachi, Pakistan. The Lancet. Global health, (2020).","DOI":"10.1016\/S2214-109X(20)30290-4"},{"issue":"38","key":"10.1016\/j.vaccine.2021.09.037_b0155","doi-asserted-by":"crossref","first-page":"11887","DOI":"10.1073\/pnas.1504964112","article-title":"Impact of human mobility on the emergence of dengue epidemics in Pakistan","volume":"112","author":"Wesolowski","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10193","key":"10.1016\/j.vaccine.2021.09.037_b0160","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(19)31279-6","article-title":"The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study","volume":"394","author":"Van Damme","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.vaccine.2021.09.037_b0165","unstructured":"GPEI. nOPV2 Frequently Asked Questions. July 2020. Available at: http:\/\/polioeradication.org\/wp-content\/uploads\/2020\/07\/nOPV2-FAQs-REVISED-202007.pdf."},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.037_b0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2017.03.013","article-title":"The Evolutionary Pathway to Virulence of an RNA Virus","volume":"169","author":"Stern","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2021.09.037_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2002468","article-title":"Assessing the stability of polio eradication after the withdrawal of oral polio vaccine","volume":"16","author":"Famulare","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.vaccine.2021.09.037_b0180","unstructured":"Pakistan Bureau of Statistics. Government of Pakistan. Pakistan Social and Living Standards Measurement Survey 2018-19. Available at: http:\/\/www.pbs.gov.pk\/content\/pakistan-social-and-living-standards-measurement."},{"issue":"9753","key":"10.1016\/j.vaccine.2021.09.037_b0185","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(10)61230-5","article-title":"Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial","volume":"376","author":"Sutter","year":"2010","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.vaccine.2021.09.037_b0190","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3201\/eid2203.151394","article-title":"Faster Detection of Poliomyelitis Outbreaks to Support Polio Eradication","volume":"22","author":"Blake","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2021.09.037_b0195","unstructured":"GPEI. Polio eradication in the context of the COVID-19 pandemic. Updated urgent country and regional recommendations. Available at: http:\/\/polioeradication.org\/wp-content\/uploads\/2020\/03\/updated-POB-country-and-regional-recommendations-20200526.pdf."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21012287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21012287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:23:46Z","timestamp":1759404226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21012287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":38,"alternative-id":["S0264410X21012287"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}